Effect of bluetongue serotype 3 vaccines on probability of viremia and NSAID usage in Dutch dairy cattle herds
IntroductionAfter the outbreak of bluetongue serotype 3 (BTV3) in The Netherlands in September 2023, three pharmaceutical companies developed inactivated vaccines against this newly emerged serotype in a short period of time, making it possible to start a vaccination campaign just before the start o...
Saved in:
| Main Authors: | Reinard R. Everts, Margit Groenevelt, Kees-Jan Oosterhuis, Elske Kelderman, Gerrit Koop |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Veterinary Science |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2025.1619614/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emergence of Bluetongue Virus Serotype 3 in Portugal (2024)
by: Sílvia C. Barros, et al.
Published: (2024-11-01) -
The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus
by: Luis Jiménez-Cabello, et al.
Published: (2025-05-01) -
Fatal Bluetongue Virus Serotype 3 Infection in Female Dogs: A Case Report from Alentejo, Portugal, 2024
by: Sílvia C. Barros, et al.
Published: (2025-01-01) -
Increased Virulence of <i>Culicoides</i> Midge Cell-Derived Bluetongue Virus in IFNAR Mice
by: Barbara S. Drolet, et al.
Published: (2024-09-01) -
Bluetongue’s New Frontier—Are Dogs at Risk?
by: Rita Payan-Carreira, et al.
Published: (2025-05-01)